{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:06:28Z","timestamp":1790355988746,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.nbd.2020.104770","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:31:59Z","timestamp":1579807919000},"page":"104770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models"],"prefix":"10.1016","volume":"137","author":[{"given":"Senthilkumar","family":"Krishnaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella S.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Don","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar M.","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.nbd.2020.104770_bb0005","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2020.104770_bb0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.nbd.2020.104770_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018296","article-title":"Chronic intranasal treatment with an anti-Abeta(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"6","author":"Cattepoel","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.nbd.2020.104770_bb0020","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/hmg\/ddp101","article-title":"Prevention of oculopharyngeal muscular dystrophy by muscular expression of llama single-chain intrabodies in vivo","volume":"18","author":"Chartier","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 10","key":"10.1016\/j.nbd.2020.104770_bb0025","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.nbd.2020.104770_bb0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"49","key":"10.1016\/j.nbd.2020.104770_bb0035","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-016-0126-z","article-title":"Affinity of tau antibodies for solubilized pathological tau species but not their immunogen or insoluble tau aggregates predicts in vivo and ex vivo efficacy","volume":"11","author":"Congdon","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2020.104770_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2019.03.033","article-title":"Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy","volume":"42","author":"Congdon","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.nbd.2020.104770_bb0050","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/mp.2016.59","article-title":"Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of tau pathology","volume":"22","author":"Dourlen","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"21","key":"10.1016\/j.nbd.2020.104770_bb0055","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1093\/hmg\/ddv321","article-title":"Anti-Abeta single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's disease","volume":"24","author":"Fernandez-Funez","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.nbd.2020.104770_bb0060","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1073\/pnas.072027199","article-title":"Filamentous phage as vector-mediated antibody delivery to the brain","volume":"99","author":"Frenkel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2020.104770_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(99)00232-5","article-title":"Modulation of Alzheimer\u2019s beta-amyloid neurotoxicity by site-directed single-chain antibody","volume":"106","author":"Frenkel","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2006.03.145","article-title":"Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model","volume":"344","author":"Fukuchi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2020.104770_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nbd.2006.04.012","article-title":"Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease","volume":"23","author":"Fukuchi","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.nbd.2020.104770_bb0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/mabs.25424","article-title":"Early intervention in the 3xTg-AD mice with an amyloid beta-antibody fragment ameliorates first hallmarks of Alzheimer disease","volume":"5","author":"Gimenez-Llort","year":"2013","journal-title":"MAbs."},{"issue":"46","key":"10.1016\/j.nbd.2020.104770_bb0085","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.494922","article-title":"Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology","volume":"288","author":"Gu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6686","key":"10.1016\/j.nbd.2020.104770_bb0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.nbd.2020.104770_bb0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.20162125","article-title":"AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy","volume":"214","author":"Ising","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7561","key":"10.1016\/j.nbd.2020.104770_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"issue":"59","key":"10.1016\/j.nbd.2020.104770_bb0105","article-title":"Mechanistic studies of antibody-mediated clearance of tau aggregates using an ex vivo brain slice model","volume":"2","author":"Krishnamurthy","year":"2011","journal-title":"Front Psychiatry"},{"issue":"50","key":"10.1016\/j.nbd.2020.104770_bb0110","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2755-14.2014","article-title":"Antibody-derived in vivo imaging of tau pathology","volume":"34","author":"Krishnaswamy","year":"2014","journal-title":"J. Neurosci."},{"issue":"46","key":"10.1016\/j.nbd.2020.104770_bb0115","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2795-06.2006","article-title":"Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta 40, and amyloid beta 42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice","volume":"26","author":"Levites","year":"2006","journal-title":"J. Neurosci."},{"issue":"22","key":"10.1016\/j.nbd.2020.104770_bb0120","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/bi049933o","article-title":"Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity","volume":"43","author":"Liu","year":"2004","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.nbd.2020.104770_bb0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1523\/JNEUROSCI.3916-05.2006","article-title":"Functional dissection of a neuronal network required for cuticle tanning and wing expansion in Drosophila","volume":"26","author":"Luan","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2020.104770_bb0130","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019398","article-title":"Dosage compensation in Drosophila","volume":"7","author":"Lucchesi","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11594-2","article-title":"Anti-Abeta single-chain variable fragment antibodies restore memory acquisition in a Drosophila model of Alzheimer\u2019s disease","volume":"7","author":"Martin-Pena","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.nbd.2020.104770_bb0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1073\/pnas.1607215114","article-title":"Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation","volume":"114","author":"McEwan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2020.104770_bb0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jmb.2009.01.061","article-title":"Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers","volume":"387","author":"Meli","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104770_bb0150","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awx052","article-title":"Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model","volume":"140","author":"Nisbet","year":"2017","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.nbd.2020.104770_bb0155","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1242\/dev.00503","article-title":"Targeted ablation of CCAP neuropeptide-containing neurons of Drosophila causes specific defects in execution and circadian timing of ecdysis behavior","volume":"130","author":"Park","year":"2003","journal-title":"Development"},{"issue":"4570","key":"10.1016\/j.nbd.2020.104770_bb0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.6289436","article-title":"Genetic transformation of Drosophila with transposable element vectors","volume":"218","author":"Rubin","year":"1982","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.nbd.2020.104770_bb0165","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/mt.2010.111","article-title":"Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer\u2019s disease mice","volume":"18","author":"Ryan","year":"2010","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.nbd.2020.104770_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051068","article-title":"Passive Abeta immunotherapy: current achievements and future perspectives","volume":"23","author":"Schilling","year":"2018","journal-title":"Molecules."},{"issue":"10","key":"10.1016\/j.nbd.2020.104770_bb0180","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jalz.2016.01.013","article-title":"Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach","volume":"12","author":"Shamir","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2020.104770_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4939-7816-8_22","article-title":"Live imaging of pathological tau protein and tau antibodies in a neuron-like cellular model","volume":"1779","author":"Shamir","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"s1","key":"10.1016\/j.nbd.2020.104770_bb0190","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.3233\/JAD-179937","article-title":"Tau immunotherapies for Alzheimer\u2019s disease and related tauopathies: progress and potential pitfalls","volume":"64","author":"Sigurdsson","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104770_bb0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.pmbts.2019.06.001","article-title":"Alzheimer\u2019s therapy development: a few points to consider","volume":"168","author":"Sigurdsson","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-018-1869-0","article-title":"Selective targeting of 3 repeat tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders","volume":"136","author":"Spencer","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104770_bb0210","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neurobiolaging.2014.12.002","article-title":"Isolation and characterization of antibody fragments selective for toxic oligomeric tau","volume":"36","author":"Tian","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104770_bb0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.mcb.2017.06.006","article-title":"The Drosophila model system to study tau action","volume":"141","author":"Trotter","year":"2017","journal-title":"Methods Cell Biol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13311-015-0397-z","article-title":"Immunotherapeutic approaches targeting amyloid-beta, alpha-synuclein, and tau for the treatment of neurodegenerative disorders","volume":"13","author":"Valera","year":"2016","journal-title":"Neurotherapeutics."},{"issue":"1","key":"10.1016\/j.nbd.2020.104770_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0585-2","article-title":"Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice","volume":"6","author":"Vitale","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2020.104770_bb0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.febslet.2008.12.064","article-title":"Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett."},{"issue":"5530","key":"10.1016\/j.nbd.2020.104770_bb0235","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1062382","article-title":"Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles","volume":"293","author":"Wittmann","year":"2001","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.nbd.2020.104770_bb0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0505321102","article-title":"Suppression of Huntington\u2019s disease pathology in Drosophila by human single-chain Fv antibodies","volume":"102","author":"Wolfgang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104770_bb0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ebiom.2018.08.041","article-title":"Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging","volume":"35","author":"Wu","year":"2018","journal-title":"EBioMedicine."},{"issue":"2","key":"10.1016\/j.nbd.2020.104770_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12031-012-9877-3","article-title":"Muscle-directed anti-Abeta single-chain antibody delivery via AAV1 reduces cerebral Abeta load in an Alzheimer's disease mouse model","volume":"49","author":"Yang","year":"2013","journal-title":"J. Mol. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:42Z","timestamp":1760851122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120300450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":48,"alternative-id":["S0969996120300450"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104770","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104770"}}